Clinical Trial: Study on Clinical and Pathological Features of Primary Biliary Cholangitis and Risk Factors Related to Disease Progression

U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07733882) titled 'Study on Clinical and Pathological Features of Primary Biliary Cholangitis and Risk Factors Related to Disease Progression' on July 24.

Brief Summary: Primary biliary cholangitis (PBC) is a chronic autoimmune intrahepatic cholestatic liver disease characterized by progressive, non-suppurative, destructive cholangitis, potentially leading to fibrosis, cirrhosis, and liver failure. It predominantly affects middle-aged and elderly women, with highly variable progression rates: some patients remain stable long-term, while others rapidly develop portal hypertension and decompensation. Early risk factor identification and accurate risk st...